menu
    • menu

    Company profile for Psyence

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Psilocybin has dominated the news cycle from the Wall Street Journal to the Financial Times. Public opinion has shifted attitudes toward psychedelics and healing; patients, families, and physicians are demanding new solutions. Governments and regulators are listening and so is the Psyence Group. We are working towards providing safe, legal psilocybin-based solutions. Breaking new ground, Psyence established one of the first l...
    Psilocybin has dominated the news cycle from the Wall Street Journal to the Financial Times. Public opinion has shifted attitudes toward psychedelics and healing; patients, families, and physicians are demanding new solutions. Governments and regulators are listening and so is the Psyence Group. We are working towards providing safe, legal psilocybin-based solutions. Breaking new ground, Psyence established one of the first legal and federally licensed commercial natural psilocybin cultivation and production facilities in the world in 2020, in the Kingdom of Lesotho

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PsyenceCanada Flag
    Country
    Country
    Canada
    Address
    Address
    200 Bay Street, Toronto, ON, M5J2J1
    Telephone
    Telephone
    +1-416-477-1708
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://psyence.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/the-psyence-group/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/PsyenceGroup

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Psyence Extends Amalgamation Timeline Deal
    Psyence Extends Amalgamation Timeline Deal

    24 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-24/psyence-group-inc-enters-into-amending-agreement-to-extend-amalgamation-timeline-with-goldcoast-res

    PHARMIWEB
    24 Feb 2026
    Share Share
    Psyence Biomed Approves Put Option Agreement With Psylabs
    Psyence Biomed Approves Put Option Agreement With Psylabs

    13 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/13/3238373/0/en/Psyence-BioMed-Approves-Put-Option-Agreement-with-PsyLabs-to-Secure-Strategic-Supply-and-Strengthen-Commercialization-Pathway.html

    GLOBENEWSWIRE
    13 Feb 2026
    Share Share
    Psyence BioMed Launches Phase IIb Psilocybin Trial
    Psyence BioMed Launches Phase IIb Psilocybin Trial

    19 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/19/3208411/0/en/Psyence-BioMed-Announces-Approval-for-Use-of-PsyLabs-Psilocybin-Product-in-Phase-IIb-Clinical-Trial.html

    GLOBENEWSWIRE
    19 Dec 2025
    Share Share
    Psyence Biomed Launches Psilocybin Longevity Research Program
    Psyence Biomed Launches Psilocybin Longevity Research Program

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194192/0/en/Psyence-BioMed-Announces-Groundbreaking-Psilocybin-Longevity-Research-Program.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Psyence Group Enters Amalgamation Agreement With Goldcoast Corp.
    Psyence Group Enters Amalgamation Agreement With Goldcoast Corp.

    24 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-24/psyence-group-inc-enters-into-amalgamation-agreement-with-goldcoast-resource-corp

    PHARMIWEB
    24 Nov 2025
    Share Share
    Psyence Group Inc. Announces RSU Grants
    Psyence Group Inc. Announces RSU Grants

    17 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-17/psyence-group-inc-announces-rsu-grants

    PHARMIWEB
    17 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search